Assembly Biosciences (ASMB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2012 | 03-2012 | 12-2011 | 09-2011 | 06-2011 | |
| Operating Expenses | 7,478 | 8,190 | 18,888 | 5,546 | 6,902 |
| Operating Income | -7,478 | -8,190 | -18,888 | -5,546 | -6,902 |
| Interest Expense | 0 | 0 | 0 | 284 | 66 |
| Other Income | 8 | 16 | 28 | 28 | 6 |
| Pre-tax Income | -7,470 | -8,174 | -18,859 | -5,801 | -6,962 |
| Net Income Continuous | -7,470 | -8,174 | -18,859 | -5,801 | -6,962 |
| Net Income | $-7,470 | $-8,174 | $-18,859 | $-5,801 | $-6,962 |
| EPS Basic Total Ops | -35.41 | -39.62 | -103.24 | -30.01 | -58.22 |
| EPS Basic Continuous Ops | -35.51 | -39.54 | -103.36 | -29.98 | -58.23 |
| EPS Diluted Total Ops | -35.41 | -39.62 | -103.24 | -30.01 | -58.22 |
| EPS Diluted Continuous Ops | -35.51 | -39.54 | -103.36 | -29.98 | -58.23 |
| EBITDA(a) | $-7,477 | $-8,189 | $-18,887 | $-5,265 | $-6,852 |